NCT07673523

Brief Summary

Diabetes is a chronic metabolic disease in which nutrients such as carbohydrates, fats and proteins cannot be utilized sufficiently due to the inability to produce insulin or defects in the effect of the produced insulin. The risk of individuals encountering complications related to diabetes decreases when glycemic control is achieved in these patients. Therefore, nutrition is an necessary component of treatment. Although there are many studies in the literature examining the effect of carbohydrate intake on glycemic control in individuals with diabetes and monitoring carbohydrate intake in individuals with diabetes is the basic strategy for reaching glucose targets, a common denominator has not yet been reached for the optimal amount of carbohydrate intake for individuals with diabetes. There are a wide range of definitions regarding carbohydrate intake and studies on carbohydrate restriction, especially in individuals with Type 1 diabetes, are limited. In present randomized controlled crossover study, three isocaloric different dietary treatment are planned to applied for 2 weeks in which (i) 30% of the daily energy requirement is provided from carbohydrates, not to fall below 130 g/day carbohydrates according to the individual characteristics of the patients, (ii) 50-55% of the daily energy requirement is provided from carbohydrates and (iii) carbohydrate content in the diet is adjusted without increasing the amount of carbohydrates, by supplementing 2 sachets (1 sachet 3.68 g inulin + 3.68 g ) where 50-55% of daily energy requirement is provided from carbohydrates together with fructooligosaccharide (FOS)) inulin fructooligosaccharide (FOS) supplementation. A 2-week washout period is planned between each diet model. The research will be conducted with 20 individuals with Type 1 diabetes using a Continuous Glucose Monitoring device. The proposed project aims to investigate the effect of different dietary treatments on glycemic control in individuals with Type 1 diabetes by using a continuous glucose measuring device. At the end of each dietary treatment application, the data obtained from the Continuous Glucose Measuring Device will be evaluated as the primary outcomes; total insulin dose, insulin/Carbohydrate ratio, total bolus insulin dose will be evaluated as the secondary outcomes. As a result of the research, the potential effects of different dietary treatments on glycemic control will be evaluated and the development of the most appropriate diet model for these patients will be contributed. In addition, this research will contribute to the improvement of the continuous glucose monitoring device.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 11, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 23, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 29, 2026

Completed
21 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 20, 2026

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 27, 2026

Completed
Last Updated

June 29, 2026

Status Verified

May 1, 2026

Enrollment Period

2 months

First QC Date

June 23, 2026

Last Update Submit

June 23, 2026

Conditions

Keywords

Type 1 Diabetes MellitusDietary treatmentCarbohdyrate intakeInulin SupplementationContinuous Glucose Monitoring

Outcome Measures

Primary Outcomes (1)

  • Continuous Glucose Measuring Device Measurements

    From the enrollment to the end of treatment at 8 weeks

Secondary Outcomes (1)

  • Other measurements

    From the enrollment to the end of the treatment at 12 weeks

Study Arms (3)

30% of the daily energy requirement is provided from carbohydrates, not to fall below 130 g/day carb

EXPERIMENTAL
Other: Dietary carbohydrate 30%

50-55% of the daily energy requirement is provided from carbohydrates

EXPERIMENTAL
Other: Dietary carbohydrate 50-55%

carbohydrate content in the diet is adjusted without increasing the amount of carbohydrates, by supp

EXPERIMENTAL
Dietary Supplement: fructooligosaccharide and inulin

Interventions

Carbohydrate content of diet

carbohydrate content in the diet is adjusted without increasing the amount of carbohydrates, by supp

Dietary carbohydrate is 30% of daily energy requirements

30% of the daily energy requirement is provided from carbohydrates, not to fall below 130 g/day carb

Dietary carbohydrate is 50-55% of daily energy requirements

50-55% of the daily energy requirement is provided from carbohydrates

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 18-65 years diagnosed with Type 1 diabetes and currently using a Continuous Glucose Monitoring device

You may not qualify if:

  • Individuals with type 2 diabetes
  • Individuals with gestational diabetes
  • Breastfeeding individuals
  • Individuals with celiac disease
  • Individuals with gastroparesis
  • Renal insufficiency (tGFR ≤ 60 ml/min/1.73 m2)
  • Diagnosed liver failure
  • Immunodeficiency
  • Individuals with malignancy
  • Using nutritional supplements that may affect metabolic parameters

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hacettepe University

Ankara, 06100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Interventions

fructooligosaccharideInulin

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

StarchGlucansBiopolymersPolymersMacromolecular SubstancesDietary CarbohydratesCarbohydratesFructansPolysaccharides

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 23, 2026

First Posted

June 29, 2026

Study Start

May 11, 2026

Primary Completion

July 20, 2026

Study Completion

July 27, 2026

Last Updated

June 29, 2026

Record last verified: 2026-05

Locations